1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)
(
- Contribution to journal › Published meeting abstract
-
Mark
Expression of P53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5Q)
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0257-0257(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Long Term Efficacy And Tolerability Of Anagrelide In Myeloproliferative Disorders
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0746-0746(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
(
- Contribution to journal › Article
- 2004
-
Mark
Automated methods for improved protein identification by peptide mass fingerprinting
(
- Contribution to journal › Article
-
Mark
Modular, scriptable and automated analysis tools for high-throughput peptide mass fingerprinting
(
- Contribution to journal › Article
-
Mark
Improving automatic peptide mass fingerprint protein identification by combining many peak sets
(
- Contribution to journal › Article
-
Mark
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders
(
- Contribution to journal › Article